Dr. Joe O'Sullivan on Utilizing Radium-223 Treatment Earlier in Patients With mCRPC
Joe O'Sullivan, MD, on utilizing radium-223 treatment earlier in patients with metastatic castration-resistant prostate cancer (mCRPC).